Equities
  • Price (USD)0.1609
  • Today's Change0.006 / 3.77%
  • Shares traded78.20k
  • 1 Year change-68.44%
  • Beta2.7269
Data delayed at least 15 minutes, as of Nov 22 2024 20:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. It is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

  • Revenue in USD (TTM)2.29m
  • Net income in USD-33.46m
  • Incorporated2018
  • Employees102.00
  • Location
    Renalytix PLCFinsgate, 5-7 Cranwood StreetLONDON EC1V 9EEUnited KingdomGBR
  • Phone+44 292 071 0570
  • Websitehttps://renalytix.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Inspira Technologies Oxy BHN Ltd0.00-11.29m24.89m37.00--3.68-----0.9549-0.95490.000.36660.00----0.00-88.60-114.98-108.36-159.56------------0.00------24.64------
Neuronetics Inc72.71m-36.42m25.32m201.00--2.70--0.3482-1.22-1.222.450.30940.87022.404.57358,182.30-43.59-28.02-54.01-34.7375.7075.73-50.09-51.042.87-3.730.8306--9.426.2218.76--18.57--
Know Labs Inc0.00-16.90m25.94m12.00---------0.1987-0.19870.00-0.020.00----0.00-277.97-212.56-1,477.22-787.19-------2,027.31---11.211.84------17.36---3.66--
Positron Corp1.24m-1.27m28.26m22.00------22.85-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
DarioHealth Corp23.05m-44.23m28.30m249.00--0.4443--1.23-1.29-1.290.64221.870.2132.714.8683,521.74-43.80-73.26-50.02-87.5939.9029.54-205.62-293.541.32--0.3303---26.4122.450.5091--52.42--
IRIDEX Corp48.43m-11.04m28.61m111.00--10.91--0.5908-0.6764-0.67642.960.15771.492.818.03436,315.30-33.90-19.54-56.74-27.4638.8242.67-22.79-15.450.845--0.5125---8.964.02-26.81---24.35--
Icecure Medical Ltd3.34m-13.69m29.63m71.00--2.79--8.88-0.2934-0.29340.07140.21430.17530.843615.0646,985.91-71.93-54.89-92.10-68.6640.3249.87-410.22-313.192.54--0.00--4.6723.5013.70--48.10--
Adagio Medical Holdings Inc0.00-2.54m30.52m----0.7637-----0.1856-0.18560.002.990.00-------6.73---9.12--------------0.1226-------299.85------
Precision Optics Corporation Inc18.98m-3.80m32.32m84.00--3.19--1.70-0.6207-0.62073.111.601.054.214.96225,954.20-20.92-9.07-29.39-13.3828.7233.05-20.01-7.270.7585-15.480.2035---9.2222.93-1,940.92--14.88--
Renalytix PLC (ADR)2.29m-33.46m32.47m102.00------14.19-0.6497-0.64970.0428-0.10180.1186--3.06---173.34-89.70-609.95-117.396.82---1,461.60-1,669.64---7.0613.35---32.74--26.64---79.60--
BioSig Technologies Inc39.00k-15.45m33.26m4.00------852.91-1.48-1.480.0033-0.0180.0171--0.8219,750.00-672.27-269.73---363.1164.10---39,405.13-24,485.73---2,513.29-----93.71---6.52---9.58--
Co-Diagnostics Inc7.32m-41.28m33.85m155.00--0.5306--4.62-1.38-1.380.24422.000.08091.2814.8747,232.32-45.605.77-48.526.1549.3082.24-563.9210.946.70--0.000.00-80.09179.54-148.15--101.27--
Vivos Inc23.00k-2.96m36.95m10.00--30.98--1,606.71-0.0076-0.00760.000060.00290.0164--3.54---210.86-202.25-223.27-552.77-29.1310.79-12,884.70-11,969.07----0.00---46.58---17.19------
Beyond Air Inc2.34m-55.49m37.49m107.00--1.33--16.01-1.42-1.420.05770.38960.04222.266.1621,887.85-106.11-78.25-134.30-99.91-97.65---2,514.82-6,152.995.38-25.130.2766-----31.57-7.93--152.05--
Outset Medical Inc114.73m-140.94m39.95m480.00--0.8354--0.3482-2.77-2.772.250.91020.38221.443.29239,018.80-46.94-41.40-55.82-47.2930.975.71-122.84-159.055.04-11.240.8048--13.00130.43-6.04--14.27--
DIH Holding US Inc67.62m-6.14m40.54m192.00------0.5996-0.1903-0.19031.96-0.98411.994.1211.80352,161.50-18.09------48.86---9.09--0.4221-3.38----19.26---732.64------
Data as of Nov 22 2024. Currency figures normalised to Renalytix PLC's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Jefferson River Capital LLCas of 05 Nov 20249.82m0.00%
Pinnacle Associates Ltd.as of 30 Sep 2024846.53k0.00%
Levin Capital Strategies LPas of 30 Sep 2024555.00k0.00%
Tejara Capital Ltd.as of 30 Sep 2024499.11k0.00%
Stifel Nicolaus & Co., Inc. (Investment Management)as of 30 Sep 2024489.43k0.00%
Corient Private Wealth LLCas of 30 Sep 2024335.51k0.00%
UBS Securities LLCas of 30 Sep 2024279.60k0.00%
Nantahala Capital Management LLCas of 30 Sep 2024117.64k0.00%
Wealth Enhancement Advisory Services LLCas of 30 Sep 202463.74k0.00%
Traynor Capital Management, Inc.as of 30 Sep 202461.75k0.00%
More ▼
Data from 30 Sep 2024 - 05 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.